Caricamento...
Desvenlafaxine and Weight Change in Major Depressive Disorder
OBJECTIVE: To characterize weight change during short- and longer-term treatment with desvenlafaxine (administered as desvenlafaxine succinate) for major depressive disorder (MDD). METHOD: Data from 9 short-term, double-blind, placebo-controlled studies and 1 longer-term relapse-prevention trial con...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Physicians Postgraduate Press, Inc.
2010
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2882808/ https://ncbi.nlm.nih.gov/pubmed/20582292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/PCC.08m00746blu |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|